Tariff item · Chapter 30 · Section VI, Products of the chemical or allied industries

HS 3004 32 00Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale: containing corticosteroid hormones, their derivatives or structural analogues

Pharmaceutical products › Containing corticosteroid hormones, their derivatives or structural analogues

Customs duty
10%
Tariff rate
GST now
5%
or 0% or 18% for some goods
Import policy
Free
With a condition
Export policy
Free
Unit
kg
Duty in China
0%
On Indian goods
Landed costSearch codesDuty abroadRates as on 19 Oct 2026

Importing into India

What customs charges, what trade agreements take off, and the rules the goods must meet.

Customs duty

Customs duty on imports into India
DutyRateCharged on
Basic customs duty (BCD), MFN rate10%Assessable value
Agriculture Infrastructure and Development Cess (AIDC)NilAssessable value11/2021-Customs, S.No. 17
Social Welfare Surcharge (SWS)10% of BCD, AIDC and Health CessBCD + AIDC
Integrated GST (IGST)5%Assessable value + BCD + AIDC + SWS

Lower duty under trade agreements

Lower customs duty under India's trade agreements
AgreementCustoms dutyGoods from
ASEAN–India FTA0%Brunei, Indonesia, Cambodia, Laos, Myanmar, Malaysia, Philippines, Singapore, Thailand, Vietnam
Duty-free tariff preference for LDCs0%Afghanistan, Bangladesh, Burkina Faso, Burundi, Benin, Democratic Republic of the Congo, Central African Republic, Eritrea, Ethiopia, Gambia, Guinea, Guinea-Bissau, Haiti, Cambodia, Comoros, Laos, Liberia, Lesotho, Madagascar, Mali, Myanmar, Malawi, Mozambique, Niger, Rwanda, Sudan, Sierra Leone, Senegal, Somalia, Chad, Togo, Timor-Leste, Tanzania, Uganda, Yemen, Zambia
India–Japan CEPA0%Japan
India–Korea CEPA0%South Korea
India–Malaysia CECA0%Malaysia
India–Sri Lanka FTA0%Sri Lanka
India–UAE CEPA0%United Arab Emirates
India–UK CETA29/2026-Customs0%United Kingdom
SAFTA0%Afghanistan, Bangladesh, Bhutan, Maldives, Nepal
SAPTA0%Bangladesh, Bhutan, Maldives, Nepal
India–Australia ECTA2%Australia
SAFTA5%Sri Lanka
India–Chile PTA6%Chile
India–Oman CEPA20/2026-Customs9%Oman

Goods from Pakistan pay 200%.

Anti-dumping, countervailing and safeguard duty

None in force on this code as on 19 Oct 2026.

Clearance by other agencies

Documents: Registration Certificate (Drugs) (CDRUG); Registration Certificate (Cosmetics) (CDRUG); License to import Drugs (Excluding those specified in Schedule-X) (CDRUG).

"*Import of oxytocin is prohibited. however, import of oxytocin reference standards is allowed exclusively for test and analysis subject to submission of test license issued by the dgci/cdcso. {refer s.o.2357(e) and DGFT NOTF no.09/2015-2020 both dated 23-05-2022}.*in case of PGA facilitated bills I.E. which have not been routed through PGA for NOC,proper officer should verify and ensure that the mandatory documents-certificate of analysis - drug[0010dc], batch release certificate[0030dc], label of consignment[0110dc], registration certificate (drugs)[101dc1], import license for drugs[9111dc]have been uploaded in (E-SANCHIT) before giving out-of-charge(OOC)*import of high end and high value used/refurbished medical equipment other than critical care medical equipment, as suggested by DGHS is subject to a number of conditions and is restricted. refer O.M. issued by ministry of environment, forest and climate change dtd 15.12.2023.**Ensure compliance of CBIC Circular 40/2026-Cus dt 03-09-2026 where in the CDSCO has provided checklists for the 7 categories (I to VII) of products and a list of documents to be verified by the Customs officer against each category of the products as per Annexure-A to the circular before granting Out-of-Charge in case of PGA facilitated Bills of Entry*"

From Central Board of Indirect Taxes and Customs (CBIC), Compliance Information Portal.

Import policy (DGFT ITC(HS))

  • Free under DGFT 09/2015-2020 of 23 May 2022.
  • Condition: Import of Oxytocin is Prohibited. However, import of Oxytocin reference standards is allowed exclusively for test and analysis subject to submission of Test License issued by the DGCI /CDCSO.
Notes on these rates
  • BCD is the statutory tariff rate from a one-time snapshot of the Indian Trade Portal. Exemption notifications (such as 45/2025-Customs) and tariff changes made after the snapshot, including the Finance Act 2026 changes from 1 May 2026, are not applied.
  • IGST comes from our archived GST table, which still has the 12% and 28% slabs, so it may pre-date the GST rate changes of 22 September 2025. Check the current rate.
  • AIDC, Health Cess and the SWS exemptions are read from notifications 11/2021-Customs, 08/2020-Customs and 11/2018-Customs as amended (to 16/2026-Customs), and the notifications that lower AIDC for a while. SWS is 10% of BCD, AIDC and Health Cess together (Finance Act 2018, s.110), never of anti-dumping, countervailing or safeguard duty or IGST.
  • AIDC is Nil (S.No. 17 of 11/2021-Customs, which exempts all goods it does not name).
  • Not included: GST compensation cess, anti-dumping, countervailing and safeguard duties, and exemptions or concessions such as end-use, EOU/SEZ or project imports.
  • This does not check whether the import is allowed (DGFT import policy, licences, quality-control orders). The HS code explorer shows the import policy.
  • This is an estimate, not an assessment. Confirm the duty with your customs broker or ICEGATE's duty calculator before you price a deal.

GST

IGST on imports is the GST rate. Rates changed on 22 September 2025.

  • Now 5%, or 0% or 18% for some goods.
  • Until 21 September 2025 12%, or 0% or 5% for some goods.
  • Change: Down.

The rules that set it now

GST rate rules in force
NotificationGoodsRate
9/2025-Integrated Tax (Rate)Schedule I, S.No. 234Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administ ration systems) or in forms or packings for retail sale, including Ayurvedic, Unani, homoeopathic siddha or Bio-chemic systems medicaments, put up for retail sale5%
10/2025-Integrated Tax (Rate)Schedule Exempt, S.No. 113Drugs or medicines listed in Annexure INil
9/2025-Integrated Tax (Rate)Schedule I, S.No. 224Following goods from Natural Menthol namely:- a. Menthol and menthol crystals, b. Peppermint (Mentha Oil), c. Fractionated / de-terpenated mentha oil (DTMO) d. De-mentholised oil (DMO), e. Spearmint oil f. Mentha piperita oil5%
9/2025-Integrated Tax (Rate)Schedule I, S.No. 225Insulin, Cyclosporin, Desferrioxamine injection or deferiprone, Oral re-hydration salts5%
9/2025-Integrated Tax (Rate)Schedule I, S.No. 226All Drugs and medicines including their salts and esters and diagnostic test kits; formulations manufactured from bulk drugs [other than those specified at nil at S. No. 113 of notification No. 10/2025-Integrated Tax (Rate) dated 17th September, 2025]5%
9/2025-Integrated Tax (Rate)Schedule I, S.No. 227Diagnostic kits for detection of all types of hepatitis5%
9/2025-Integrated Tax (Rate)Schedule I, S.No. 228Medicaments (including veterinary medicaments) used in bio- chemic systems5%
9/2025-Integrated Tax (Rate)Schedule I, S.No. 229Medicaments (including those used in Ayurvedic, Unani, Siddha, Homeopathic or Bio-chemic systems), manufactured exclusively in accordance with the formulae described in the authoritative books specified in the First Schedule to the Drugs and Cosmetics Act, 1940 (23 of 1940) or Homeopathic Pharmacopoeia of India or the United States of America or the United Kingdom or the German Homeopathic Pharmacopoeia, as the case may be, and sold under the name as specified in such books or pharmacopoeia5%
9/2025-Integrated Tax (Rate)Schedule II, S.No. 38Following goods made from other than natural menthol, namely:- a. Menthol and menthol crystals, b. Peppermint (Mentha Oil) c. Fractionated / de-terpenated mentha oil (DTMO) d. De-mentholised oil (DMO) e. Spearmint oil f. Mentha piperita oil18%

History

GST rate history
PeriodRateNotification
Until 15 Jan 20255% or 12%1/2017-Central Tax (Rate)
16 Jan 2025 to 21 Sep 20250%, 5% or 12%1/2017-Central Tax (Rate); 2/2025-Central Tax (Rate)
From 22 Sep 20250%, 5% or 18%9/2025-Integrated Tax (Rate); 10/2025-Integrated Tax (Rate)

Exporting from India

Export duty

Nil. The Second Schedule to the Customs Tariff Act does not list these goods, so no export duty is charged.

Duty drawback (All Industry Rates)

All Industry Rates of duty drawback under this heading
Drawback itemGoodsRateCap
3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale1.2%—

Drawback items follow the 4-digit heading, not the 8-digit code: claim the one that describes your goods. Rates of notification 77/2023-Customs (N.T.) as amended, in force on 19 Oct 2026.

Export incentives (RoDTEP and RoSCTL)

  • RoDTEP, Appendix 4R (exports from the domestic tariff area): 0.7% of the FOB value, until 31 Dec 2026.
  • RoDTEP, Appendix 4RE (exports under Advance Authorisation, EOU or SEZ): 0.4% of the FOB value, until 31 Dec 2026.

Clearance by other agencies

*FOR DRUGS AND PHARMACEUTICALS CDSCO NOC IS REQD EXCEPT WHEN EXEMPTED.REF-DCGI/MISC/2015(199) ORDER DTD 21.3.18* AS PER CIR NO.47/2017-CUS DTD 27/11/2017 FOR THE PURPOSE OF GRANT OF DRAWBACK WHEREVER EXPORT CONSIGNMENTS ARE SELECTED FOR ASSESSMENT OR EXAMINATION, THE AC/DC SHALL DETERMINE THE NEED TO DRAW SAMPLE ON MERITS OF EACH CASE.IF THE PACKING IS OF WOODEN MATERIAL, ENSURE THE VALID PHYTOSANITARY CERTIFICATE AND ISPM-15 MARKING COMPLIANCE AS PER CBEC INSTR. F.NO.450/19/2005-CUS-IV DTD 16.9.13.*

From Central Board of Indirect Taxes and Customs (CBIC), Compliance Information Portal.

Export policy (DGFT ITC(HS) Schedule 2)

  • Free under DGFT 45078 of 22 May 2023.
  • Condition: Subject to Policy Condition 1 of the Chapter

What buyers pay abroad: import duty in the US, UK, EU and Australia for 3004 32, and China's below.

China: the same goods (3004 32)

China shares the first 6 digits with India and splits them into 10-digit codes of its own: 3 in force and 51 expired under 3004 32. Exporters see what China charges Indian goods; importers see the rebate and licences their Chinese supplier deals with.

China's tariff for these goods
China codeGoodsDuty on Indian goodsMFNImport VATExport rebateLicences
3004.32.00.10Medicaments containing other corticosteroid hormones listed in the 'List of Stimulants' (incl. derivatives and structural analogues, excl. antibiotics, incl. retail packings)《兴奋剂目录》所列含其他皮质甾类激素的药品（包括其衍生物及结构类似物,不含抗菌素,包括零售包装）0%APTA rate, with an APTA certificate of origin0%13%13%L
3004.32.00.61Medicaments for veterinary use, in measured doses已配剂量兽用制剂0%APTA rate, with an APTA certificate of origin0%13%13%R
3004.32.00.99Other medicaments, put up in measured doses, containing other corticosteroid hormones其他已配剂量含其他皮质甾类激素的药品0%APTA rate, with an APTA certificate of origin0%13%13%Q
  • India is a member of the Asia-Pacific Trade Agreement (APTA). With an APTA certificate of origin, Indian goods pay China's APTA rate where the line has one; China applies the lower of that and its provisional rate.
  • The export VAT rebate is what China refunds its own exporters. When China cuts it, Chinese export prices tend to rise.

Every Chinese code in full

3004.32.00Medicaments containing corticosteroid hormones, their derivatives or structural analogues, put up in measured doses or in retail packings

3004.32.00.10Medicaments containing other corticosteroid hormones listed in the 'List of Stimulants' (incl. derivatives and structural analogues, excl. antibiotics, incl. retail packings)《兴奋剂目录》所列含其他皮质甾类激素的药品（包括其衍生物及结构类似物,不含抗菌素,包括零售包装）

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
0%
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
23 Aug 2026
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
Maldives
0%
Cambodia
0%
Nicaragua
0%
Ecuador
0%
Serbia
0%
Hong Kong
0%
Macao
0%
Asia-Pacific (APTA)
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
South Korea
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
2.7%
Indonesia
0%
Philippines
0%
Myanmar
0%
CIQ codes
  • 3004320010999Medicaments containing other corticosteroid hormones listed in the "Doping List" (including derivatives and structural analogues thereof, excluding antibiotics, including in retail packings)《兴奋剂目录》所列含其他皮质甾类激素的药品(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.61Medicaments for veterinary use, in measured doses已配剂量兽用制剂

incl. goods in the import veterinary drug administration catalogue; incl. retail packings包括进口兽药管理目录的商品;包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
0%
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
23 Aug 2026
Licences and certificates
  • RImported veterinary drugs clearance certificate进口兽药通关单
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
Maldives
0%
Cambodia
0%
Nicaragua
0%
Ecuador
0%
Serbia
0%
Hong Kong
0%
Macao
0%
Asia-Pacific (APTA)
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
South Korea
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
2.7%
Indonesia
0%
Philippines
0%
Myanmar
0%
CIQ codes
  • 3004320061999Medicaments for veterinary use, put up in measured doses (including products in the import veterinary drug management catalogue; including retail packings)已配剂量兽用制剂(包括进口兽药管理目录的商品;包括零售包装)
3004.32.00.99Other medicaments, put up in measured doses, containing other corticosteroid hormones其他已配剂量含其他皮质甾类激素的药品

Residual tariff heading resulting from the splitting of anti-cancer drugs因拆分抗癌药产生的兜底税号

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
0%
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
23 Aug 2026
Licences and certificates
  • QImported drugs clearance certificate进口药品通关单
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch is approved for registration and marketing in China该批次是否在我国获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
Maldives
0%
Cambodia
0%
Nicaragua
0%
Ecuador
0%
Serbia
0%
Hong Kong
0%
Macao
0%
Asia-Pacific (APTA)
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
South Korea
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
2.7%
Indonesia
0%
Philippines
0%
Myanmar
0%
CIQ codes
  • 3004320099301Other medicaments, put up in measured doses, containing other corticosteroid hormones (incl. derivatives and structural analogues, not containing antibiotics, incl. retail packings) (hydrocortisone film-forming agent) (flammable liquid)其他已配剂量含其他皮质甾类激素的药品(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)(氢化可的松涂膜剂)(易燃液体)
  • 3004320099999Other medicaments, put up in measured doses, containing other corticosteroid hormones (incl. derivatives and structural analogues, excl. antibiotics, incl. retail packings) (residual tariff no. from splitting anti-cancer drugs) (other)其他已配剂量含其他皮质甾类激素的药品(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)(因拆分抗癌药产生的兜底税号)(其他)
3004.32.00.11Medicaments, single, in measured doses, containing 1-androstenediol or 1-androstenedione已配剂量含1-雄烯二醇或1-雄烯二酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320011999Single medicaments containing 1-androstenediol or 1-androstenedione, put up in measured doses (incl. derivatives and structural analogues thereof, incl. retail packings)已配剂量含1-雄烯二醇或1-雄烯二酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.12Medicaments, put up in measured doses, containing formebolone only已配剂量含甲酰勃龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320012999Medicaments containing formebolone, single, put up in measured doses (incl. derivatives and structural analogues, incl. retail packings)已配剂量含甲酰勃龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.13Medicaments, single, with androst-4-ene-3β, 17α-diol, put up in measured doses已配剂量含雄甾-4-烯-3β, 17α-二醇)的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320013999Medicaments, put up in measured doses, containing androst-4-ene-3β,17α-diol (4-androstenediol (3β,17α)) (including derivatives and structural analogues thereof, including retail packaging)已配剂量含雄甾-4-烯-3β,17α-二醇(4-雄烯二醇(3β,17α))的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.14Medicaments, single, with androst-5-ene-3β, 17α-diol, put up in measured doses已配剂量含雄甾-5-烯-3β, 17α-二醇)的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320014999Medicaments, put up in measured doses, containing androst-5-ene-3β,17α-diol (5-androstenediol (3β,17α)) (including derivatives and structural analogues thereof, including retail packaging)已配剂量含雄甾-5-烯-3β,17α-二醇(5-雄烯二醇(3β,17α))的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.15Medicaments, single constituent, with 4-androstenediol or ethinylestradiol, put up in measured doses已配剂量含4-雄烯二醇或乙雌烯醇的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320015999Medicaments containing 4-androstenediol or ethylestrenol, put up in measured doses (including derivatives and structural analogues, including retail packaging)已配剂量含4-雄烯二醇或乙雌烯醇的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.16Medicaments, single constituent, containing 5-androstenedione, put up in measured doses已配剂量含5-雄烯二酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320016999Medicaments, single constituent, containing 5-androstenedione (incl. derivatives and structural analogues, incl. retail packs), put up in measured doses已配剂量含5-雄烯二酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.17Single medicaments, in measured doses, containing 5α-androstane-3α, 17β-diol or 5β-androstane-3α, 17β-diol已配剂量含5α-雄烷-3α, 17β-二醇)或5β-雄烷-3α, 17β-二醇)的单方制剂Expired

Including derivatives and structural analogues thereof, including retail packages包括其衍生物及其结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320017999Medicaments, put up in measured doses, containing 5α-androstane-3α,17β-diol (androstanediol (3α,17β)) or 5β-androstane-3α,17β-diol (5β-androstanediol (3α,17β)) as the sole active ingredient (including derivatives and structural analogues thereof, including retail packings)已配剂量含5α-雄烷-3α,17β-二醇(雄烷二醇(3α,17β))或5β-雄烷-3α,17β-二醇(5β-雄烷二醇(3α,17β))的单方制剂(包括其衍生物及其结构类似物,包括零售包装)
3004.32.00.18Medicaments, single, of 5α-androstane-3β, 17α-diol, put up in measured doses已配剂量5α-雄烷-3β, 17α-二醇)的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320018999Medicaments, put up in measured doses, containing 5α-androstane-3β,17α-diol (androstane-diol (3β,17α)) (incl. derivatives and structural analogues thereof, incl. retail packings).已配剂量5α-雄烷-3β,17α-二醇(雄烷二醇(3β,17α))的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.19Medicaments, put up in measured doses, containing bolasterone only已配剂量含勃拉睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320019999Medicaments containing boldenone, single, put up in measured doses (incl. derivatives and structural analogues, incl. retail packings)已配剂量含勃拉睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.21Medicaments, put up in measured doses, containing budesonide已配剂量含勃地酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320021999Medicaments, put up in measured doses, containing boldenone (including derivatives and structural analogues thereof, including retail packing)已配剂量含勃地酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.22Medicaments, put up in measured doses, containing boldenone已配剂量含勃二酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates

None.

Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320022999Medicaments, put up in measured doses, containing boldione (including derivatives and structural analogues thereof, including retail packing)已配剂量含勃二酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.23Medicaments, measured doses, containing calusterone or danazol, not mixed已配剂量含卡芦睾酮或达那唑的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320023999Medicaments, single constituent, containing calusterone or danazol (incl. derivatives & structural analogues), put up in measured doses (incl. retail packings)已配剂量含卡芦睾酮或达那唑的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.24Medicaments, put up in measured doses, containing clostebol only已配剂量含氯司替勃的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320024999Medicaments containing clostebol, single, put up in measured doses (incl. derivatives and structural analogues, incl. retail packings)已配剂量含氯司替勃的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.25Medicaments, single constituent, containing dehydrochlormethyltestosterone, put up in measured doses已配剂量含去氢氯甲睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320025999Medicaments, single constituent, containing dehydrochlormethyltestosterone (incl. derivatives and structural analogues, incl. retail packs), put up in measured doses已配剂量含去氢氯甲睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.26Medicaments, single constituent, containing methylclostebol, put up in measured doses已配剂量含甲基氯司替勃的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320026999Medicaments, single constituent, containing methylchlorostebol (incl. derivatives and structural analogues, incl. retail packs), put up in measured doses已配剂量含甲基氯司替勃的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.27Medicaments, put up in measured doses, containing (Δ) androstenediol (incl. derivatives and structural analogues, incl. retail packings)已配剂量含(Δ)雄烯二醇的单方制剂(包括其衍生物及结构类似物,包括零售包装)Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
5.0%
Provisional import duty
None
General import duty
30.0%
Import VAT
17.0%
Consumption tax
0.0%
Export duty
0.0%
Provisional export duty
None
Export VAT rebate
15.0%
Updated by China
30 Dec 2018
Licences and certificates

None.

Inspection and quarantine

None.

What the customs declaration must state

Not listed.

China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
3004.32.00.28Medicaments containing prasterone or drostanolone, put up in measured doses已配剂量含普拉睾酮或屈他雄酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320028999Medicaments containing prasterone or drostanolone (including derivatives and structural analogues), put up in measured doses or for retail sale已配剂量含普拉睾酮或屈他雄酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.29Medicaments, single constituent, containing desoxymethyltestosterone or dihydrotestosterone, put up in measured doses已配剂量含去氧甲睾酮或双氢睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320029999Medicaments, put up in measured doses, containing desoxymethyltestosterone or dihydrotestosterone (incl. derivatives and structural analogues thereof, incl. retail packings)已配剂量含去氧甲睾酮或双氢睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.31Medicaments, single constituent, containing epidihydrotestosterone or fluoxymesterone, put up in measured doses已配剂量含表双氢睾酮或氟甲睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320031999Medicaments, n.e.s., containing epihydrotestosterone or fluoxymesterone (incl. derivatives and structural analogues thereof, in retail packs)已配剂量含表双氢睾酮或氟甲睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.32Medicaments, put up in measured doses, containing furazabol only已配剂量含夫拉扎勃的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320032999Medicaments containing furazabol, single, put up in measured doses (incl. derivatives and structural analogues, incl. retail packings)已配剂量含夫拉扎勃的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.33Medicaments, single constituent, with gestrinone or 4-hydroxytestosterone, put up in measured doses已配剂量含孕三烯酮或4-羟基睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320033999Medicaments containing gestrinone or 4-hydroxytestosterone, put up in measured doses (including derivatives and structural analogues, including retail packaging)已配剂量含孕三烯酮或4-羟基睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.34Single constituent preparations containing 3α-hydroxy-5α-androstan-17-one含3α-羟基-5α-雄烷-17-酮的单方制剂Expired

Including their derivatives and structural analogues, put up in measured doses or in forms or packings for retail sale包括其衍生物及结构类似物,已配剂量或制成零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates

None.

Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320034999Single preparations containing 3α-hydroxy-5α-androstan-17-one (incl. derivatives & structural analogues thereof), put up in measured doses or in retail packings含3α-羟基-5α-雄烷-17-酮的单方制剂(包括其衍生物及结构类似物,已配剂量或制成零售包装)
3004.32.00.35Medicaments, put up in measured doses, containing mesterolone or mesterone已配剂量含美睾酮或美雄酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320035999Medicaments, put up in measured doses, containing mesterolone or mestanolone (incl. derivatives and structural analogues, incl. retail packings)已配剂量含美睾酮或美雄酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.36Medicaments, single constituent, containing methenolone, put up in measured doses已配剂量含甲基屈他雄酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320036999Medicaments, single constituent, containing metyldrostanolone (incl. derivatives and structural analogues, incl. retail packs), put up in measured doses已配剂量含甲基屈他雄酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.37Medicaments, single constituent, containing methadienone, put up in measured doses已配剂量含甲二烯诺龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320037999Single medicaments containing metandienone, in measured doses (incl. derivatives and structural analogues, incl. retail packings)已配剂量含甲二烯诺龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.38Medicaments, single constituent, containing methyl-1-testosterone or methenolone, put up in measured doses已配剂量含甲基-1-睾酮或甲诺睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320038999Medicaments, single, put up in measured doses, containing methyl-1-testosterone or methandienone (incl. derivatives and structural analogues thereof, incl. retail packings)已配剂量含甲基-1-睾酮或甲诺睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.39Medicaments, put up in measured doses, containing metribolone only已配剂量含美曲勃龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320039999Single medicaments in measured doses, containing metribolone (incl. derivatives & structural analogues, incl. retail packings)已配剂量含美曲勃龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.41Medicaments containing mesterolone or metenolone, put up in measured doses已配剂量含美雄诺龙或美替诺龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320041999Medicaments containing mesterolone or methenolone (including derivatives and structural analogues), put up in measured doses or for retail sale已配剂量含美雄诺龙或美替诺龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.42Medicaments, single constituent, with mesterolone or methyltestosterone or mibolerone, put up in measured doses已配剂量含美雄醇或甲睾酮或米勃酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320042999Medicaments containing mesterolone or methyltestosterone or mibolerone, put up in measured doses (including derivatives and structural analogues, including retail packaging)已配剂量含美雄醇或甲睾酮或米勃酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.43Medicaments, single constituent, with nandrolone or norbolethone or norstisterone, put up in measured doses已配剂量含诺龙或诺勃酮或诺司替勃的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320043999Medicaments containing nandrolone or norbolethone or norstebol, put up in measured doses (including derivatives and structural analogues, including retail packaging)已配剂量含诺龙或诺勃酮或诺司替勃的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.44Medicaments containing 19-norandrostenedione, put up in measured doses已配剂量含19-去甲雄烯二酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320044999Medicaments containing 19-norandrostenedione (including derivatives and structural analogues), put up in measured doses or for retail sale已配剂量含19-去甲雄烯二酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.45Medicaments containing nandrolone or norethandrolone, put up in measured doses已配剂量含去甲雄酮或诺乙雄龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320045999Medicaments containing nandrolone or norethandrolone (including derivatives and structural analogues), put up in measured doses or for retail sale已配剂量含去甲雄酮或诺乙雄龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.46Medicaments, put up in measured doses, containing 19-norpregnane-4,17-diol-3-one已配剂量含19-去甲本胆烷醇酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320046999Medicaments, put up in measured doses, containing 19-norandrostanolone (incl. derivatives and structural analogues thereof, incl. retail packings)已配剂量含19-去甲本胆烷醇酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.47Medicaments, put up in measured doses, containing oxymetholone or oxandrolone已配剂量含羟勃龙或氧雄龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320047999Medicaments, put up in measured doses, containing oxymetholone or oxandrolone (incl. derivatives and structural analogues, incl. retail packings)已配剂量含羟勃龙或氧雄龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.48Medicaments containing oxymetholone or oxymesterone, put up in measured doses已配剂量含羟甲睾酮或羟甲烯龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320048999Medicaments containing oxymetholone or oxandrolone (including derivatives and structural analogues), put up in measured doses or for retail sale已配剂量含羟甲睾酮或羟甲烯龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.49Medicaments, put up in measured doses, containing prostalozol only已配剂量含前列他唑的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320049999Medicaments containing drostanolone, single, put up in measured doses (incl. derivatives and structural analogues, incl. retail packings)已配剂量含前列他唑的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.51Single formulations containing quibolol, tibolone or trenbolone含奎勃龙或替勃龙或群勃龙的单方制剂Expired

Including their derivatives and structural analogues, put up in measured doses or in forms or packings for retail sale包括其衍生物及结构类似物,已配剂量或制成零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320051999Single medicaments containing quibolone, tibolone or trenbolone (incl. derivatives & structural analogues), in measured doses or retail packings含奎勃龙或替勃龙或群勃龙的单方制剂(包括其衍生物及结构类似物,已配剂量或制成零售包装)
3004.32.00.52Medicaments containing stanozolol or methenolone, put up in measured doses已配剂量含司坦唑醇或司腾勃龙的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320052999Medicaments containing stanozolol or stenbolone (including derivatives and structural analogues), put up in measured doses or for retail sale已配剂量含司坦唑醇或司腾勃龙的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.53Medicaments, put up in measured doses, containing 1-testosterone or testosterone已配剂量含1-睾酮或睾酮的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320053999Medicaments, put up in measured doses, containing 1-testosterone or testosterone (incl. derivatives and structural analogues, incl. retail packings)已配剂量含1-睾酮或睾酮的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.54Medicaments, single constituent, containing gestrinone or zeranol, put up in measured doses已配剂量含四氢孕三烯酮或泽仑诺的单方制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320054999Medicaments, n.e.s., containing gestrinone or zearalenone (incl. derivatives and structural analogues thereof, in retail packs)已配剂量含四氢孕三烯酮或泽仑诺的单方制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.60Betamethasone valerate preparations, for veterinary use, put up in measured doses兽用已配剂量倍他米松戊酸酯制剂Expired

And their derivatives and structural analogues, including retail packings包括其衍生物及结构类似物,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
4 Jan 2021
Licences and certificates
  • RImported veterinary drugs clearance certificate进口兽药通关单
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses or in retail packings是否配定剂量或零售包装
  • 5.Brand品牌
  • 6.Packing specifications包装规格
  • 7.GTIN
  • 8.CAS
China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
CIQ codes
  • 3004320060999Veterinary medicaments of betamethasone valerate (incl. derivatives and structural analogues thereof, incl. retail packings), put up in measured doses兽用已配剂量倍他米松戊酸酯制剂(包括其衍生物及结构类似物,包括零售包装)
3004.32.00.71Medicaments, single, with androst-5-ene-3β, 17β-diol, put up in measured doses已配剂量含雄甾-5-烯-3β, 17β-二醇)的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320071999Medicaments, put up in measured doses, containing androst-5-ene-3β,17β-diol (5-androstenediol (3β,17β)) (incl. derivatives and structural analogues, not containing antibiotics, incl. retail packings)已配剂量含雄甾-5-烯-3β,17β-二醇(5-雄烯二醇(3β,17β))的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.72Medicaments, put up in measured doses, containing androst-4-ene-3,17-dione, single constituent已配剂量含雄甾-4-烯-3,17-二酮的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320072999Medicaments, put up in measured doses, containing androst-4-ene-3,17-dione (4-androstenedione) (incl. derivatives and structural analogues thereof, not containing antibiotics, incl. retail packings).已配剂量含雄甾-4-烯-3,17-二酮(4-雄烯二酮)的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.73Medicaments, put up in measured doses, containing boldenone only已配剂量含勃雄二醇的单方制剂Expired
Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
16%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
16%
Updated by China
30 Dec 2018
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state

Not listed.

China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
CIQ codes
  • 3004320073999Medicaments, put up in measured doses, containing boldenone (incl. derivatives and structural analogues thereof, not containing antibiotics, incl. retail packings)已配剂量含勃雄二醇的单方制剂(包括其衍生物及结构类似物,不含抗菌素，包括零售包装)
3004.32.00.74Medicaments, put up in measured doses, containing 7α-hydroxy-dehydroepiandrosterone已配剂量含7α-羟基-普拉睾酮的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320074999Medicaments, put up in measured doses, containing 7α-hydroxy-prasterone (incl. derivatives & structural analogues, excl. antibiotics, incl. retail packings)已配剂量含7α-羟基-普拉睾酮的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.75Medicaments, put up in measured doses, containing 7β-hydroxy-dehydroepiandrosterone已配剂量含7β-羟基-普拉睾酮的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320075999Medicaments, put up in measured doses, containing 7β-hydroxy-prasterone (incl. derivatives & structural analogues, excl. antibiotics, incl. retail packings)已配剂量含7β-羟基-普拉睾酮的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.76Medicaments containing 7-keto-dehydroepiandrosterone, put up in measured doses已配剂量含7-羰基-普拉睾酮的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320076999Medicaments, single, in measured doses, containing 7-keto-prasterone (incl. derivatives and structural analogues thereof, not containing antibiotics, incl. retail packings)已配剂量含7-羰基-普拉睾酮的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.77Medicaments, put up in measured doses, containing cholanolone only已配剂量含胆烷醇酮的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320077999Medicaments, n.e.s., containing cholanolone (incl. derivatives and structural analogues thereof, not containing antibiotics, in retail packs)已配剂量含胆烷醇酮的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.78Medicaments, measured doses, containing 1,4-androstenedione, not mixed已配剂量含1,4-雄烯二酮的单方制剂Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
13%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
1 Jan 2025
Licences and certificates
  • LPharmaceuticals import/export permit药品进出口准许证
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses是否配定剂量
  • 5.Whether in retail packings是否零售包装
  • 6.Chemical common name化学通用名
  • 7.Whether the batch has been approved for registration and marketing该批次是否已获准注册上市
  • 8.Brand (Chinese or foreign names)品牌(中文或外文名称)
  • 9.Packing specifications包装规格
  • 10.GTIN
  • 11.CAS
  • 12.Other其他
China's agreement rates
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
RCEP rates
Australia
0%
Brunei
0%
Cambodia
0%
Laos
0%
Malaysia
0%
New Zealand
0%
Singapore
0%
Thailand
0%
Vietnam
0%
Japan
4.5%
CIQ codes
  • 3004320078999Medicaments, put up in measured doses, containing 1,4-androstenedione (androsta-1,4-diene-3,17-dione) (including derivatives and structural analogues thereof, not containing antibiotics, including retail packaging)已配剂量含1,4-雄烯二酮(雄甾-1,4-二烯-3,17-二酮)的单方制剂(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.90Medicaments containing other corticosteroid hormones, put up in measured doses (incl. derivatives and structural analogues thereof, not containing antibiotics, incl. retail packings)已配剂量含其他皮质甾类激素的药品(包括其衍生物及结构类似物,不含抗菌素,包括零售包装 )Expired

Including derivatives and structural analogues thereof, not containing antibiotics, including in retail packings包括其衍生物及结构类似物,不含抗菌素,包括零售包装

Unit
kg
MFN import duty
5%
Provisional import duty
None
General import duty
30%
Import VAT
17%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
15%
Updated by China
30 Dec 2018
Licences and certificates
  • QImported drugs clearance certificate进口药品通关单
Inspection and quarantine

None.

What the customs declaration must state

Not listed.

China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
CIQ codes
  • 3004320090101Medicaments, put up in measured doses, containing other corticosteroid hormones (including derivatives and structural analogues, not containing antibiotics, including retail packaging) (hydrocortisone film-forming agent) (medium flash-point liquid)已配剂量含其他皮质甾类激素的药品(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)(氢化可的松涂膜剂)(中闪点液体)
  • 3004320090999Medicaments, put up in measured doses, containing other corticosteroid hormones (incl. derivatives and structural analogues thereof, not containing antibiotics, incl. retail packings)已配剂量含其他皮质甾类激素的药品(包括其衍生物及结构类似物,不含抗菌素,包括零售包装)
3004.32.00.91Anti-cancer medicaments (excluding adjuvant therapy medicaments for cancer)抗(防)癌药品制剂(不含癌症辅助治疗药品)Expired
Unit
kg
MFN import duty
0%
Provisional import duty
None
General import duty
30%
Import VAT
3%
Consumption tax
None
Export duty
0%
Provisional export duty
None
Export VAT rebate
13%
Updated by China
4 Jan 2021
Licences and certificates
  • QImported drugs clearance certificate进口药品通关单
Inspection and quarantine

None.

What the customs declaration must state
  • 0.Brand type品牌类型
  • 1.Export preferential status出口享惠情况
  • 2.Use用途
  • 3.Ingredients成分
  • 4.Whether put up in measured doses or in retail packings是否配定剂量或零售包装
  • 5.Brand品牌
  • 6.Packing specifications包装规格
  • 7.GTIN
  • 8.CAS
China's agreement rates
ASEAN
0%
Chile
0%
Pakistan
0%
New Zealand
0%
Peru
0%
Costa Rica
0%
Switzerland
0%
Iceland
0%
Australia
0%
South Korea
0%
Georgia
0%
Mauritius
0%
CIQ codes
  • 3004320091999Anti-cancer medicaments (excluding adjuvant therapy medicaments for cancer)抗(防)癌药品制剂(不含癌症辅助治疗药品)

China's tariff as compiled by HS编码网 from China Customs, the State Council Tariff Commission and the State Taxation Administration. The Chinese is the original.

Nearby codes

Previous3004 31 90OtherOne level up3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail saleNext3004 39 11Pituitary hormones

Sources

For information, not a customs ruling. Only notifications published in the Gazette have legal force; confirm the duty with your customs broker or ICEGATE before you price a deal.